.Novo Nordisk is continuing its press right into hereditary medications, accepting compensate NanoVa...
.Innovent Biologics has actually created the scenario that its checkpoint inhibitor-cytokine fusion ...
.A period 3 test of Daiichi Sankyo and Merck & Co.'s HER3-directed antibody-drug conjugate (ADC) ...
.5 months after Rakovina Therapeutics rotated toward expert system, the cancer-focused biotech has p...
.Ascendis Pharma has emerged as a potential risk to BioMarin's Voxzogo, reporting phase 3 growth con...
.Though Alkeus Pharmaceuticals' dental eye health condition property fell short to considerably mini...
.Along with a triad of biotechs hitting the Nasdaq on Friday, it was actually very easy to miss a sm...
.Invulnerable checkpoint inhibitors are the superheroes of cancer cells therapy. Medicines like Bris...
.Accept to recently's Chutes & Ladders, our roundup of significant management hirings, firings an...
.Regeneron is back along with long-term consequence for its LAG-3 prevention and also PD-1 inhibitor...